PG
ORCL icon

Prostatis Group’s Oracle ORCL Stock Holding History

Prostatis Group’s Portfolio ORCL Stock Details ORCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$240K Sell
1,641
-325
-17% -$58.9K 0.06% 163
2026
Q1 		$289K Sell
1,966
-1,203
-38% -$196K 0.07% 145
2025
Q4 		$618K Buy
3,169
+2,095
+195% +$499K 0.15% 93
2025
Q3 		$302K Buy
+1,074
New +$273K 0.08% 130

Other funds holding ORCL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Prostatis Group's ORCL Position: Q2 2026 in Review

Prostatis Group reduced its Oracle (ORCL) stake by 17% in Q2 2026, selling an estimated $58.9K and leaving 1,641 shares worth $240K. The position accounts for 0.06% of the portfolio, ranked #163.

Prostatis Group first reported a position in ORCL in Q3 2025 and has held it in 4 quarters since. The position peaked at $618K in Q4 2025. 3,362 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Prostatis Group held 1,641 shares of Oracle worth $240K as of Q2 2026.
  • Prostatis Group sold 325 Oracle shares in Q2 2026, an estimated $58.9K.
  • Oracle made up 0.06% of Prostatis Group's portfolio in Q2 2026, its #163 holding.
  • Prostatis Group first reported a position in Oracle in Q3 2025 and has held it in 4 quarters since.
  • Prostatis Group's Oracle position peaked at $618K in Q4 2025.
  • 3,362 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.